Trial Details
Not RecruitingBasic Information
| Clinical ID | c2941 |
|---|---|
| Identifier | JPRN-UMIN000022104 |
| Trial Title | Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients. - Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | - |
Participant Information
| Sponsor | Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine |
|---|---|
| City | - |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |